GTG developing a genetic test in the fight against COVID-19
May 22, 2020
May 22, 2020 |
Genetic Technologies (ASX: GTG | NASDAQ: GENE) is fast-tracking development of a genetic test that will determine if people are at a high risk of contracting COVID-19.
GTG Signs Prestigious Collaboration Agreement for Fight Against Cancer
Oct 2, 2019
Oct 2, 2019 |
Emerging med-tech junior Genetic Technologies (ASX:GTG | NASDAQ:GENE) understands the importance of timely and precise targeting. Accessible predictive risk testing is where GTG lives and it has now signed a 3-year Collaboration Agreement with high profile US-based researcher Translational Genomics Research Institute (TGen).
Genetic Technologies surges 40% on back of agreement
Sep 23, 2019
Sep 23, 2019 |
Provider of world-leading genetic risk assessment test products Genetic Technologies Limited (ASX:GTG), has signed a 3-year Collaboration Agreement with TGen.
GTG Validates Cancer Tests As it Looks to Global Expansion
May 14, 2019
May 14, 2019 |
What if there was a cost effective way for patients to assess their cancer risk and seek treatment? There is. Genetic Technologies (ASX:GTG; NASDAQ:GENE).
Genetic Technologies shares rocket after cancer tests validated
May 13, 2019
May 13, 2019 |
Shares in Genetic Technologies Ltd (ASX:GTG; NASDAQ:GENE) surged nearly 60% on Friday after the company announced two new ground-breaking cancer risk assessment tests had been completed and validated.